John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$191M |
| 2 |
Intel
INTC
|
+$190M |
| 3 |
Qualcomm
QCOM
|
+$188M |
| 4 |
Procter & Gamble
PG
|
+$158M |
| 5 |
PepsiCo
PEP
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$120M |
| 2 |
Costco
COST
|
+$107M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$98.4M |
| 5 |
Eli Lilly
LLY
|
+$75.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.46% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Technology | 13.9% |
| 4 | Consumer Staples | 9.5% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Royal Bank of Canada
RY
$281B
| $6.75M | 0.03% |
+99,520
| New | +$6.33M |
|
|
ALXN
527
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.71M | 0.03% |
59,821
-297,071
| -83% | -$31.5M |
|
528
Chefs' Warehouse
CHEF
$4.55B
| $6.71M | 0.03% |
494,259
+412,981
| +508% | +$5.7M |
|
529
Grand Canyon Education
LOPE
$3.88B
| $6.69M | 0.03% |
73,941
-104,750
| -59% | -$9.32M |
|
530
Domo
DOMO
$177M
| $6.68M | 0.03% |
207,786
+145,987
| +236% | +$3.25M |
|
531
Kinross Gold
KGC
$39.5B
| $6.67M | 0.03% |
924,047
-4,262,451
| -82% | -$27.7M |
|
532
Ecolab
ECL
$79.7B
| $6.66M | 0.03% |
33,474
-22,520
| -40% | -$4.36M |
|
|
WBA
533
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $6.64M | 0.03% |
156,700
+4,300
| +3% | +$183K |
|
534
Intuit
INTU
$100B
| $6.57M | 0.03% |
+22,185
| New | +$6.09M |
|
535
Akamai
AKAM
$15.6B
| $6.57M | 0.03% |
61,337
+5,146
| +9% | +$517K |
|
|
BLDP
536
Ballard Power Systems
BLDP
$696M
| $6.56M | 0.03% |
426,003
-15,480
| -4% | -$169K |
|
537
Cameco
CCJ
$44.3B
| $6.52M | 0.03% |
+636,446
| New | +$6.36M |
|
538
AnaptysBio
ANAB
$1.68B
| $6.51M | 0.03% |
291,536
+6,801
| +2% | +$124K |
|
|
TWTR
539
PUT
DELISTED
Twitter, Inc.
TWTR
| $6.51M | 0.03% |
218,500
+10,700
| +5% | +$323K |
|
540
Nektar Therapeutics
NKTR
$2.49B
| $6.5M | 0.03% |
+18,719
| New | +$5.84M |
|
541
Kulicke & Soffa
KLIC
$4.38B
| $6.48M | 0.03% |
310,919
+254,988
| +456% | +$5.77M |
|
542
Silicon Laboratories
SLAB
$7.27B
| $6.47M | 0.03% |
64,552
+43,752
| +210% | +$4.09M |
|
|
AMED
543
DELISTED
Amedisys
AMED
| $6.47M | 0.03% |
32,592
-1,443
| -4% | -$269K |
|
544
Allegiant Air
ALGT
$2.27B
| $6.45M | 0.03% |
59,027
+42,534
| +258% | +$3.89M |
|
|
MXIM
545
DELISTED
Maxim Integrated Products
MXIM
| $6.42M | 0.03% |
105,909
+1,254
| +1% | +$69.8K |
|
546
Stellantis
STLA
$19.9B
| $6.41M | 0.03% |
626,047
-721,293
| -54% | -$6.23M |
|
|
CADE
547
DELISTED
Cadence Bancorporation
CADE
| $6.41M | 0.03% |
723,086
-247,789
| -26% | -$1.77M |
|
|
YMAB
548
DELISTED
Y-mAbs Therapeutics
YMAB
| $6.38M | 0.03% |
147,675
+26,895
| +22% | +$1.02M |
|
|
MODN
549
DELISTED
MODEL N, INC.
MODN
| $6.36M | 0.03% |
182,912
+2,911
| +2% | +$84.8K |
|
|
BHVN
550
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.34M | 0.03% |
86,744
+1,781
| +2% | +$94.8K |
|
Similar funds
John Overdeck's Q2 2020 Portfolio in Review
As of Q2 2020, John Overdeck held 3,794 positions worth $20.2B, up 64% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
John Overdeck deployed $4.35B of net new capital in Q2 2020, opening 798 new positions and adding to 974 existing holdings. Its largest new stake was Kroger: 3,903,595 shares worth $132M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $104M trimmed.
- John Overdeck's largest Q2 2020 buy was Kroger: 3,903,595 shares worth $132M.
- John Overdeck added most to Lowe's Companies in Q2 2020, an estimated $191M increase.
- John Overdeck's biggest Q2 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $104M.
- John Overdeck fully exited Starbucks in Q2 2020, selling an estimated $120M.
- John Overdeck's ten largest holdings make up 12% of its $20.2B portfolio in Q2 2020.
- John Overdeck opened 798 new positions and closed 913 in Q2 2020.
- John Overdeck's portfolio value rose 64% quarter-over-quarter to $20.2B.
Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.